Page last updated: 2024-08-26

10-hydroxy-2-decenoic acid and Muscular Atrophy

10-hydroxy-2-decenoic acid has been researched along with Muscular Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Goto, A; Inoue, A; Kawamoto, T; Kokabu, S; Matsubara, T; Miyawaki, A; Morikawa, K; Nakai, N; Okamoto, H; Okumura, N; Rojasawasthien, T; Shirakawa, T; Tsujisawa, T; Washio, A	1

Other Studies

1 other study(ies) available for 10-hydroxy-2-decenoic acid and Muscular Atrophy

Article	Year
Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal Muscle Atrophy. Nutrients, 2020, Oct-11, Volume: 12, Issue:10 Topics: Administration, Oral; Animals; Cells, Cultured; Decanoic Acids; Denervation; Fatty Acids; Fatty Acids, Monounsaturated; Insulin-Like Growth Factor I; Mice, Inbred C57BL; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Peptide Hydrolases; Receptor, IGF Type 1; Sarcopenia	2020

Article

Year

Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal Muscle Atrophy.

Nutrients, 2020, Oct-11, Volume: 12, Issue:10

Topics: Administration, Oral; Animals; Cells, Cultured; Decanoic Acids; Denervation; Fatty Acids; Fatty Acids, Monounsaturated; Insulin-Like Growth Factor I; Mice, Inbred C57BL; Muscle Development; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Peptide Hydrolases; Receptor, IGF Type 1; Sarcopenia

2020